Teva Pharma AG - Abirateron-Teva 500 mg, Filmtabletten | | 68319 | | 01 | | Abirateron-Teva 500 mg | | Filmtabletten | | L02BX03 | | Abiraterone | | 02.05.2022 | | |
| Composition | abirateroni acetas 500 mg corresp. abirateronum 446.0 mg, lactosum monohydricum 90 mg, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 9.96 mg. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose |
---|
Abirateroni Acetas | 500 mg correspond Abirateronum 446 mg |
| BAG: Active Agent | Dose |
---|
Abirateroni Acetas | 500 mg |
| | Inactive agents | Dose | additional_information |
---|
(Flavum) | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Lactose Monohydrate | 90 mg | | Macrogol | 3350 | | Magnesii Stearas | | | Natrii Laurilsulfas | | | Poly(Alcohol Vinylicus) | | Überzug | Povidonum K | 30 | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 56 | 897.80 | 992.05 | B | | Yes |
|
|